A detailed history of Al Ti Global, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Al Ti Global, Inc. holds 164,335 shares of BMY stock, worth $9.57 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
164,335
Previous 107,268 53.2%
Holding current value
$9.57 Million
Previous $4.45 Billion 90.86%
% of portfolio
0.2%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $2.26 Million - $2.95 Million
57,067 Added 53.2%
164,335 $8.5 Billion
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $3.84 Million - $5.05 Million
95,291 Added 795.62%
107,268 $4.45 Billion
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $105,220 - $119,299
2,193 Added 22.41%
11,977 $650 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $474,328 - $566,004
9,784 New
9,784 $502 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Al Ti Global, Inc. Portfolio

Follow Al Ti Global, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Al Ti Global, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Al Ti Global, Inc. with notifications on news.